AtriCure
$29.689876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (+0.10%) Today
$0.00 (0.00%) As of 4:01 PM EST after-hours
Why Robinhood?
You can buy or sell AtriCure and other stocks, options, ETFs, and crypto commission-free!
About ATRC
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. Read More It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.
Employees
620
Headquarters
Mason, Ohio
Founded
2000
Market Cap
1.17B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
142.52K
High Today
$29.82
Low Today
$29.38
Open Price
$29.70
Volume
139.34K
52 Week High
$33.92
52 Week Low
$22.57
Collections
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
ATRC Earnings
-$0.33
-$0.28
-$0.22
-$0.17
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 27, After Hours